Clinical Trial Update: Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial update on autologous bone marrow mononuclear cells transplantation for type 1 and type 2 diabetes; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow mononuclear cells transplantation

Snippet

Sponsor: Shandong University | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: UNKNOWN